ATE389021T1 - Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff - Google Patents

Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff

Info

Publication number
ATE389021T1
ATE389021T1 AT98919756T AT98919756T ATE389021T1 AT E389021 T1 ATE389021 T1 AT E389021T1 AT 98919756 T AT98919756 T AT 98919756T AT 98919756 T AT98919756 T AT 98919756T AT E389021 T1 ATE389021 T1 AT E389021T1
Authority
AT
Austria
Prior art keywords
hepatitis
proteins
vaccine
virus
rrecombinant
Prior art date
Application number
AT98919756T
Other languages
English (en)
Inventor
Suzanne Emerson
Robert Purcell
Sergei A Tsarev
Robin Robinson
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE389021T1 publication Critical patent/ATE389021T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/28011—Hepeviridae
    • C12N2770/28111—Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT98919756T 1997-04-11 1998-04-09 Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff ATE389021T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/840,316 US6054567A (en) 1997-04-11 1997-04-11 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines

Publications (1)

Publication Number Publication Date
ATE389021T1 true ATE389021T1 (de) 2008-03-15

Family

ID=25282015

Family Applications (2)

Application Number Title Priority Date Filing Date
AT08004467T ATE530563T1 (de) 1997-04-11 1998-04-09 Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen
AT98919756T ATE389021T1 (de) 1997-04-11 1998-04-09 Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT08004467T ATE530563T1 (de) 1997-04-11 1998-04-09 Rekombinante proteine einer pakistanischen hepatitis e variante und ihre verwendung in diagnoseverfahren und impfungen

Country Status (10)

Country Link
US (1) US6054567A (de)
EP (2) EP1958958B1 (de)
JP (1) JP4390293B2 (de)
CN (1) CN1202252C (de)
AT (2) ATE530563T1 (de)
AU (1) AU739915B2 (de)
CA (1) CA2286399C (de)
DE (1) DE69839242T2 (de)
ES (1) ES2301195T3 (de)
WO (1) WO1998046761A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1345775A (zh) 2000-09-30 2002-04-24 养生堂有限公司 用于预防、诊断及治疗戊型肝炎病毒的多肽,及它们作为诊断试剂和疫苗
US7005130B2 (en) * 2001-01-05 2006-02-28 Virginia Tech Intellectual Properties, Inc. Avian hepatitis E virus, vaccines and methods of protecting against avian hepatitis-splenomegaly syndrome and mammalian hepatitis E
AU2002308593A1 (en) * 2001-05-07 2002-11-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt Recombinant orf2 proteins of the swine hepatitis e virus and their use as a vaccine and as a diagnostic reagent for medical and veterinary applications
US20060258856A1 (en) * 2002-02-13 2006-11-16 Medimolecular Pty. Ltd. Method of isolating nucleic acids from stool samples
US20090305294A1 (en) * 2003-02-13 2009-12-10 Medimolecular Pty Ltd Method of isolating nucleic acids from stool samples
CA2920672C (en) 2013-08-14 2022-12-13 Gen-Probe Incorporated Compositions and methods for detecting hev nucleic acid
JP7777906B2 (ja) * 2022-03-01 2025-12-01 関西ペイント株式会社 木材用水性塗料組成物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5686239A (en) * 1988-06-17 1997-11-11 Genelabs Technologies, Inc. Hepatitis E virus peptides and methods
US6455492B1 (en) * 1988-06-17 2002-09-24 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5741490A (en) * 1988-06-17 1998-04-21 Genelabs Technologies, Inc. Hepatitis E virus vaccine and method
US5885768A (en) * 1988-06-17 1999-03-23 The United States Of America As Represented By The Department Of Health And Human Services Hepatitis E virus peptide antigen and antibodies
US6214970B1 (en) * 1988-06-17 2001-04-10 Genelabs Technologies, Inc. Hepatitis E virus antigens and uses therefor
WO1990001443A1 (de) 1988-08-08 1990-02-22 Iffiu Michael A Klappbares sesselrad mit stromlinienförmiger, in drei geteilter und faltbarer verkleidung
CA2016841C (en) 1989-05-16 1999-09-21 William D. Huse A method for producing polymers having a preselected activity
EP0476130B1 (de) * 1990-04-05 2008-07-09 Genelabs Technologies, Inc. Enterisch übertragendes non-a/non-b-hepatitis-virus agens und charakteristische epitope von selbigem
DE69334299D1 (de) * 1992-09-18 2009-12-31 Us Gov Health & Human Serv Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
AU694139B2 (en) * 1993-09-24 1998-07-16 Macfarlane Burnet Centre For Medical Research Limited, The Immunoreactive antigens of hepatitis E virus
JPH09507025A (ja) * 1993-12-22 1997-07-15 アボツト・ラボラトリーズ ＨＥＶ ｏｒｆ−２に対するモノクローナル抗体及びそれらを使用する方法
KR100359526B1 (ko) * 1994-10-03 2003-02-25 더 가브먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 리프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비씨즈 E형간염파키스탄형균주의재조합단백질및이를이용한진단방법과백신

Also Published As

Publication number Publication date
ATE530563T1 (de) 2011-11-15
AU739915B2 (en) 2001-10-25
JP4390293B2 (ja) 2009-12-24
WO1998046761A1 (en) 1998-10-22
CA2286399C (en) 2009-06-30
EP0972048B1 (de) 2008-03-12
EP1958958A1 (de) 2008-08-20
CN1202252C (zh) 2005-05-18
CA2286399A1 (en) 1998-10-22
EP1958958B1 (de) 2011-10-26
DE69839242D1 (de) 2008-04-24
ES2301195T3 (es) 2008-06-16
JP2001524821A (ja) 2001-12-04
DE69839242T2 (de) 2009-03-12
AU7247098A (en) 1998-11-11
EP0972048A1 (de) 2000-01-19
CN1260000A (zh) 2000-07-12
US6054567A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
ATE449178T1 (de) Rekombinante proteine eines pakistani stammes von hepatitis e-virus sowie ihre verwendung in diagnostischen verfahren und als vakzine
ES2111524T3 (es) Peptidos de eritropoyetina (epo) y anticuerpos dirigidos contra ellos.
BR9906927A (pt) Proteìnas de neisseria meningitidis
PT804584E (pt) Sequencias de virus da hepatite c genotipo 7 e sua utilizacao como agentes profilacticos terapeuticos e de diagnostico
ATE552340T1 (de) Hepatitis c virus genotypsequenzen sowie ihre verwendung als behandlungs- und nachweismitteln
DE59209921D1 (de) Seroreaktive Bereiche auf den HPV 16 Proteinen E1 und E2
EP1542732A4 (de) Fusionsproteine aus mycobakterium tuberculosis
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
ATE183241T1 (de) Impstoff gegen streptococcus suis-infektion
EP0593290A3 (de) Kernantigenprotein des Hepatitis C-Virus, sowie diagnostisches Verfahren und Satz von Reagenzen.
ATE389021T1 (de) Rrekombinante proteine eines pakistani-stammes von hepatitis-e-virus, ihre verwendung in diagnotischen verfahren und als impfstoff
DE69638024D1 (de) Melanoma antigene p15 und deren anwendung in diagnostischen und therapeutischen verfahren
NL300336I2 (nl) Vaccin tegen de bof dat een jeryl-lynn virusstam bevat
KR970706300A (ko) E형 간염 파키스탄형 균주의 재조합 단백질 및 이를 이용한 진단방법과 백신(recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines)
PT1035133E (pt) Proteinas de fusao compreendendo veiculos que podem induzir uma dupla resposta imune
SE9201281D0 (sv) New human monoclonal antibodies, and a method for preparation thereof
ATE248188T1 (de) Monoklonale antikörper gegen das epitop ypydvpdya,verfahren zu deren herstellung und ihre verwendung
DK0491713T3 (da) Rubella El-peptider og C-peptider
NZ309172A (en) Neutralizing conformational epitopes of chicken anemia virus
CA2080213A1 (en) Diagnostic reagent for hepatitis c
ATE128733T1 (de) Monoklonale antikörper gegen hiv gp120.
CA2141670A1 (en) Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.
IT1284630B1 (it) Epitopi specifici di virus associati a epatiti non"a"-non"e", composizioni e metodo per rivelare anticorpi di detti epitopi.
MX9709851A (es) Epitopes neutralizadores conformacionales del virus de la anemia de pollo.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties